The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Kumar, Ajay, Dr
    Director born in April 1981
    Individual (79 offsprings)
    Officer
    2015-09-22 ~ now
    OF - Director → CIF 0
    Dr. Ajay Kumar
    Born in April 1981
    Individual (79 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 2
  • 1
    Kumar, Rajinder, Dr
    Director born in December 1955
    Individual (2 offsprings)
    Officer
    2015-09-22 ~ 2023-02-20
    OF - Director → CIF 0
    Dr Rajinder Kumar
    Born in December 1955
    Individual (2 offsprings)
    Person with significant control
    2016-09-21 ~ 2018-09-29
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Dr. Ajay Kumar
    Born in April 1981
    Individual (79 offsprings)
    Person with significant control
    2016-09-21 ~ 2023-05-19
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

CAMNORD PHARMA LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Debtors
35,465 GBP2023-09-30
414,525 GBP2022-09-30
Cash at bank and in hand
2,256,680 GBP2023-09-30
817,555 GBP2022-09-30
Current Assets
2,292,145 GBP2023-09-30
1,232,080 GBP2022-09-30
Creditors
Current
3,304,405 GBP2023-09-30
149,650 GBP2022-09-30
Net Current Assets/Liabilities
-1,012,260 GBP2023-09-30
1,082,430 GBP2022-09-30
Total Assets Less Current Liabilities
-1,012,260 GBP2023-09-30
1,082,430 GBP2022-09-30
Equity
Called up share capital
123 GBP2023-09-30
123 GBP2022-09-30
Share premium
3,184,404 GBP2023-09-30
3,184,404 GBP2022-09-30
Retained earnings (accumulated losses)
-4,196,787 GBP2023-09-30
-2,102,097 GBP2022-09-30
Equity
-1,012,260 GBP2023-09-30
1,082,430 GBP2022-09-30
Average Number of Employees
22022-10-01 ~ 2023-09-30
22021-10-01 ~ 2022-09-30
Other Debtors
Current, Amounts falling due within one year
35,465 GBP2023-09-30
414,525 GBP2022-09-30
Trade Creditors/Trade Payables
Current
139,032 GBP2023-09-30
21,588 GBP2022-09-30
Other Taxation & Social Security Payable
Current
12,130 GBP2023-09-30
6,239 GBP2022-09-30
Other Creditors
Current
3,153,243 GBP2023-09-30
121,823 GBP2022-09-30
  • CAMNORD PHARMA LIMITED
    Info
    Registered number 09789742
    23 Portugal Place, Cambridge CB5 8AF
    Private Limited Company incorporated on 2015-09-22 (9 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.